Effect of Dietary Components on Gastrointestinal Side Effects Induced by Orlistat, a Lipase Inhibitor

Trial Profile

Effect of Dietary Components on Gastrointestinal Side Effects Induced by Orlistat, a Lipase Inhibitor

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Sep 2014

At a glance

  • Drugs Orlistat (Primary)
  • Indications Obesity
  • Focus Adverse reactions
  • Acronyms ORLIFAT
  • Most Recent Events

    • 02 Sep 2014 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov record.
    • 29 Mar 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top